DPSCREEN: Dynamic Personalized Screening

Screening is important for the diagnosis and treatment of a wide variety of diseases. A good screening policy should be personalized to the disease, to the features of the patient and to the dynamic history of the patient (including the history of screening). The growth of electronic health records data has led to the development of many models to predict the onset and progression of different diseases. However, there has been limited work to address the personalized screening for these different diseases. In this work, we develop the first framework to construct screening policies for a large class of disease models. The disease is modeled as a finite state stochastic process with an absorbing disease state. The patient observes an external information process (for instance, self-examinations, discovering comorbidities, etc.) which can trigger the patient to arrive at the clinician earlier than scheduled screenings. The clinician carries out the tests; based on the test results and the external information it schedules the next arrival. Computing the exactly optimal screening policy that balances the delay in the detection against the frequency of screenings is computationally intractable; this paper provides a computationally tractable construction of an approximately optimal policy. As an illustration, we make use of a large breast cancer data set. The constructed policy screens patients more or less often according to their initial risk -- it is personalized to the features of the patient -- and according to the results of previous screens – it is personalized to the history of the patient. In comparison with existing clinical policies, the constructed policy leads to large reductions (28-68 %) in the number of screens performed while achieving the same expected delays in disease detection.

[1]  Kee-Eung Kim,et al.  Point-Based Value Iteration for Constrained POMDPs , 2011, IJCAI.

[2]  Rongwei Fu,et al.  Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[3]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[4]  Raman Arora,et al.  Disease Trajectory Maps , 2016, NIPS.

[5]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[6]  J. Lortet-Tieulent,et al.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.

[7]  Turgay Ayer,et al.  OR Forum - A POMDP Approach to Personalize Mammography Screening Decisions , 2012, Oper. Res..

[8]  Lisa M. Maillart,et al.  Assessing Dynamic Breast Cancer Screening Policies , 2008, Oper. Res..

[9]  Nancy N. Baxter Breast self-examination , 2002 .

[10]  S. Greenfield,et al.  Overtreatment of men with low‐risk prostate cancer and significant comorbidity , 2011, Cancer.

[11]  Fatih Safa Erenay,et al.  Optimizing Colonoscopy Screening for Colorectal Cancer Prevention and Surveillance , 2014, Manuf. Serv. Oper. Manag..

[12]  Rob Boer,et al.  The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..

[13]  Dimitris Rizopoulos,et al.  Dynamic Predictions and Prospective Accuracy in Joint Models for Longitudinal and Time‐to‐Event Data , 2011, Biometrics.

[14]  H. Nelson,et al.  Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[15]  M. Kimmey,et al.  Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. , 2003, Gastrointestinal endoscopy.

[16]  G. A. Whitmore,et al.  First Hitting Time Models for Lifetime Data , 2003, Advances in Survival Analysis.

[17]  Sarah M. Greene,et al.  Efficacy of breast cancer screening in the community according to risk level. , 2005, Journal of the National Cancer Institute.

[18]  Arash Naeim,et al.  The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care , 2013, Breast Cancer Research and Treatment.

[19]  Sankey V. Williams,et al.  Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians , 2007, Annals of Internal Medicine.

[20]  Nancy L Keating,et al.  A systematic assessment of benefits and risks to guide breast cancer screening decisions. , 2014, JAMA.

[21]  Oguzhan Alagoz,et al.  Operations Research Models for Cancer Screening , 2011 .

[22]  Oguzhan Alagoz,et al.  Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. , 2016, Annals of internal medicine.

[23]  M. Crowder Classical Competing Risks , 2001 .

[24]  Joelle Pineau,et al.  Point-based value iteration: An anytime algorithm for POMDPs , 2003, IJCAI.

[25]  D. Bertsekas,et al.  Approximate solution methods for partially observable markov and semi-markov decision processes , 2006 .

[26]  D.,et al.  Regression Models and Life-Tables , 2022 .

[27]  Roberta M Ray,et al.  Randomized trial of breast self-examination in Shanghai: final results. , 2002, Journal of the National Cancer Institute.

[28]  Ja Wilson,et al.  Principles and practice of screening for disease , 1968 .

[29]  Donghua Zhou,et al.  Remaining useful life estimation - A review on the statistical data driven approaches , 2011, Eur. J. Oper. Res..

[30]  Carmen Cadarso-Suárez,et al.  Nonparametric estimation of transition probabilities in a non-Markov illness–death model , 2006, Lifetime data analysis.

[31]  Vikram Krishnamurthy,et al.  POMDP Structural Results for Controlled Sensing , 2017, ArXiv.

[32]  Paul Fockens,et al.  International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer , 2012, Gut.

[33]  D. Winchester,et al.  Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.

[34]  Dimitris Rizopoulos,et al.  Personalized screening intervals for biomarkers using joint models for longitudinal and survival data. , 2015, Biostatistics.

[35]  C. Klabunde,et al.  Evaluating Population-Based Screening Mammography Programs Internationally. , 2007, Seminars in breast disease.

[36]  Edward J. Sondik,et al.  The Optimal Control of Partially Observable Markov Processes over a Finite Horizon , 1973, Oper. Res..

[37]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[38]  Mihaela van der Schaar,et al.  ConfidentCare: A Clinical Decision Support System for Personalized Breast Cancer Screening , 2016, IEEE Transactions on Multimedia.

[39]  Michael N Liebman,et al.  Personalized medicine: a perspective on the patient, disease and causal diagnostics. , 2007, Personalized medicine.

[40]  T. Wilt,et al.  Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2011 .

[41]  Pier Paolo Delsanto,et al.  Does tumor growth follow a "universal law"? , 2003, Journal of theoretical biology.

[42]  Vikram Krishnamurthy,et al.  Partially observed Markov decision processes (POMDPs) , 2016 .

[43]  G. A. Whitmore,et al.  Threshold Regression for Survival Analysis: Modeling Event Times by a Stochastic Process Reaching a Boundary , 2006, 0708.0346.

[44]  Mihaela van der Schaar,et al.  Balancing Suspense and Surprise: Timely Decision Making with Endogenous Information Acquisition , 2016, NIPS.

[45]  I. Verdinelli,et al.  Bayesian designs for maximizing information and outcome , 1992 .

[46]  K. L. b Appendix S1 , 2006 .

[47]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[48]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[49]  J. Austoker,et al.  Breast self examination , 2003, BMJ : British Medical Journal.